Hydra Biosciences Company

Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.
Technology: Cancer
Industry: PharmTech
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2001
Employees Number: 11-50
Funding Status: Late Stage Venture
Estimated Revenue: $1M to $10M

Visit Website
info@hydrabiosciences.com
Register and Claim Ownership